An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A company called Evolv has launched a new over-the-counter oral supplement named Evolv Grow. They’re marketing it as a next-generation product to support hair growth in men and women. The company says the formula centers on a peptide they call EV2 and includes GHK-Cu, a compound that’s already known in hair-care circles. This is a product launch story, not a clinical trial report. GHK-Cu is a small molecule made of three amino acids bound to copper. It’s been studied for wound healing, skin repair, and hair effects for decades. In hair products it’s often used topically (applied to the scalp) because some studies and cosmetic tests suggest it can stimulate hair follicles and improve hair thickness. A peptide like EV2 is a short chain of amino acids designed to mimic or influence biological signals. The company’s pitch is that their EV2 peptide works together with GHK-Cu to support hair health from inside the body when taken orally, rather than just being applied to the scalp. The announcement doesn’t present large, peer‑reviewed clinical trials showing that the pill regrows hair in humans. Product launches like this typically rely on preclinical data, lab studies, or small tests, and the press snippet doesn’t give trial details, sample sizes, or independent verification. So we don’t have solid evidence here that taking Evolv Grow will produce dramatic hair regrowth. At best, there’s a rationale based on known actions of GHK‑Cu and early-stage research on peptides; at worst, the benefits may be modest or unproven when swallowed as a supplement. Why it matters is mostly about convenience and interest. Many people dealing with thinning hair want effective, easy options beyond topical minoxidil, prescription drugs, or invasive procedures. An oral supplement that truly helped would be attractive because it’s simple to take. Also, the use of peptides reflects a trend where biotech-style ingredients are moving into consumer wellness products, which could speed innovation but also blur lines between cosmetics and medicine. There are important caveats. Supplements aren’t regulated like prescription drugs, so safety and efficacy claims aren’t vetted by regulators before products hit shelves. Oral bioavailability — whether a peptide survives digestion and reaches hair follicles intact — is a common scientific hurdle and often limits how effective an orally taken peptide can be. Side effects, interactions with medications, and long-term safety aren’t addressed in a launch announcement. People who are pregnant, breastfeeding, on other medications, or who have underlying health conditions should check with a healthcare provider before trying new supplements. Lastly, without published clinical trial data, treat marketing claims with caution. Bottom line: Evolv Grow is a new oral hair supplement built around GHK‑Cu and a proprietary peptide, but the launch does not replace solid clinical proof — so it’s interesting, not definitive.
Source: Fitt Insider